SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-21-096407
Filing Date
2021-07-27
Accepted
2021-07-27 18:30:43
Documents
2
Period of Report
2021-07-23

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2123420-2_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2123420-2_3seq1.xml 3 1614
2 EXHIBIT 24 tm2123420d2_ex24.htm EX-24 8272
  Complete submission text file 0001104659-21-096407.txt   11491
Mailing Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211
Business Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211 (310) 358-3200
CAPRICOR THERAPEUTICS, INC. (Issuer) CIK: 0001133869 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O 8840 WILSHIRE BOULEVARD 2ND FLOOR BEVERLY HILLS CA 90211
Business Address
Sabar Karimah Es (Reporting) CIK: 0001873796 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-34058 | Film No.: 211119199